Yıldız Değirmenci

Pathogenic VCP (p.Arg453Trp) variant in three siblings with frontotemporal dementia–amyotrophic lateral sclerosis spectrum: A Turkish family

Murat Gültekin, Beyzanur Altıkulaç İlikhan, Recep Baydemir, Yıldız Değirmenci et autres

tr (code pays fourni par la source)

Complementary and Integrative Medicine for the Treatment of Tourette's Syndrome

Tamara Milka Pringsheim, Saar Anis, Poonam Bhatia, KEVIN JOHN BLACK et autres

BACKGROUND: There is widespread interest in complementary and integrative medicine (CIM) among people with Tourette's syndrome (TS). OBJECTIVE: To perform a systematic review of evidence on the use of CIM to reduce tics and improve tic-related quality of life. METHODS: We included …

ca, us, tr, fr, Maroc, es, gb, hk, Nigéria, pl (code pays fourni par la source)

Amantadine improves executive and memory functions in patients with Parkinsons Disease: Double blind parallel two-arm randomized controlled trial

Anastasia M. Bougea, Εfthimia Efthymiopoulou, Yıldız Değirmenci, Panagiotis Zikos

gr, kh (code pays fourni par la source)

Editorial: Advances in Parkinson's Disease Research: Exploring Biomarkers and Therapeutic Strategies for Halting Disease Progression

Anastasia M. Bougea, Yıldız Değirmenci

Parkinson's disease (PD) is a multifactorial neurodegenerative disorder, characterized by loss of dopaminergic neurons of substantia nigra (SN) in 1% of people aged above 65 years (Ben-Shlomo et al., 2024). Its complex clinical picture includes motor symptoms such as tremor, bradykinesia, and …

gr, kh (code pays fourni par la source)

Fluid biomarkers in atypical Parkinsonism: current state and future perspectives

Anastasia M. Bougea, Carlo Colosimo, Cristian Falup-Pecurariu, Giovanni Palermo et autres

gr, it, ro, kh (code pays fourni par la source)

Management of neuroleptic malignant syndrome induced by paliperidone: A case report of multidisciplinary treatment approaches, including apomorphine and electroconvulsive therapy

Murat Gültekin, Şeyma Benli, Saliha Demirel-Özsoy, Yıldız Değirmenci

Relationship between subjective sleep quality and serum ghrelin levels in Parkinson’s disease

Alper Aziz Hüdai Ayaslı, Yıldız Değirmenci, Fatih Davran, Mehmet Alı Sungur

Objectives: This study aimed to investigate the relationship between serum ghrelin levels and subjective sleep quality in patients with Parkinson's disease (PD). Patients and methods: This prospective case-control study was conducted between July 2020 and September 2021. Sixty-three patients (39 males, 24 …

gb, tr, fi (code pays fourni par la source)

Editorial for special issue of Deep Brain Stimulation

Cihan İşler, Yıldız Değirmenci, Ersoy Kocabıçak

Movement disorders in autoimmune and paraneoplastic disorders

Yıldız Değirmenci

tr (code pays fourni par la source)

A case of tongue twisting during screening of stn dbs for parkinson’s disease: a unique form of pyramidal tract activation

Yıldız Değirmenci, Harith Akram, Dayal Viswas, Zrinzo Ludvic et autres

Subthalamic nucleus deep brain stimulation (STN-DBS) is a safe and effective therapy for Parkinson´s disease (PD) in selected patients. However, various side effects such as paraesthesia, diplopia, ataxia, worsened akinesia, emotional changes, dysarthria, and muscle contractions can occur due to the current …

tr, gb (code pays fourni par la source)

Current DBS programming

Yıldız Değirmenci

Deep brain stimulation is an established treatment option for various neurological and psychiatric disorders. Throughout its journey as a confirmed long-term efficacious therapeutic option for movement disorders such as Parkinson' s disease, essential tremor and dystonia over the last three decades, programming …

tr (code pays fourni par la source)

The future of e-learning in neurology

Barbara Tettenborn, Yıldız Değirmenci

ch, tr (code pays fourni par la source)